Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 14, 2013; 19(22): 3375-3384
Published online Jun 14, 2013. doi: 10.3748/wjg.v19.i22.3375
Table 1 National Cholesterol Education Programme Adult Treatment Panel III - 2001/American Heart Association - 2005 metabolic syndrome (diagnosis: 3 of 5)
Risk factorDefining level (AHA 2005)
Abdominal obesity (waist, inches)
Men> 40
Women> 35
Triglycerides (mg/dL)150 (or Med)
HDL-C (mg/dL)
Men< 40 (or Med)
Women< 50
BP (mmHg)130/85 (or Med)
Fasting glucose (mg/dL)110 (100)
Table 2 International Diabetes Federation: Definitions of metabolic syndrome
Central obesity plus any two of the following four factors
Raised triglyceride150 mg/dL, or specific treatment for this lipid abnormality
Reduced HDL-C< 40 mg/dL in men and < 50 mg/dL in women, or specific treatment for this lipid abnormality
Raised BPSystolic BP 130 or diastolic BP 85 mmHg, or treatment of previously diagnosed hypertension
Raised FPG100 mg/dL, or previously diagnosed type 2 diabetes. If above 100 mg/dL, OGTT is strongly recommended but is not necessary to define presence of the syndrome
Table 3 Central obesity defined according to the International Diabetes Federation
Country/ethnic groupWC
Europids (In the United States, the NCEP-ATP III values1 are likely to continue to be used for clinical purposes)
Male≥ 94 cm (37 in)
Female≥ 80 cm (32 in)
South Asians (based on a Chinese, Malay, and Asian-Indian population)
Male≥ 90 cm (35 in)
Female≥ 80 cm (32 in)
Male≥ 90 cm (35 in)
Female≥ 80 cm (32 in)
Male≥ 85 cm (34 in)
Female≥ 90 cm (32 in)